Private company

Aravive, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersTX
  • Incorporated inTX2
  • Business addressRiver Oaks Tower, 3730 Kirby Drive, Suite 1200, Houston, Tx 770982
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-775.3%Operating margin3
-835.3%Net margin3
22.8%Revenue growth, 20223
-716.2%Return on equity3
-$65.1MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Other costs100¢$9.1M

Out of $9.1M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$9.1M in 2022−77% since 2017
0$10.0M$20.0M$30.0M$40.0M2017: $40.0M$40.0M20172018: $1.4M$1.4M2018−97%2019: $4.8M$4.8M2019+247%2020: $5.7M$5.7M2020+20%2021: $7.4M$7.4M2021+31%2022: $9.1M$9.1M2022+23%
Operating income845673-$70.8M in 2022−26% since 2016
-$100.0M-$75.0M-$50.0M-$25.0M02016: -$96.3M-$96.3M20162017: -$84.5M-$84.5M2017−12%2018: -$75.4M-$75.4M2018−11%2019: -$21.8M-$21.8M2019−71%2020: -$30.8M-$30.8M2020+41%2021: -$40.6M-$40.6M2021+32%2022: -$70.8M-$70.8M2022+74%
Net income845673-$76.3M in 2022−20% since 2016
-$100.0M-$75.0M-$50.0M-$25.0M02016: -$95.8M-$95.8M20162017: -$85.0M-$85.0M2017−11%2018: -$76.3M-$76.3M2018−10%2019: -$18.2M-$18.2M2019−76%2020: -$30.5M-$30.5M2020+68%2021: -$39.2M-$39.2M2021+28%2022: -$76.3M-$76.3M2022+95%
Fiscal year2016201720182019202020212022
Revenue$40.0M4$1.4M5$4.8M6$5.7M7$7.4M3$9.1M3
Research and development$72.0M8$94.6M4$11.1M4
Operating income-$96.3M8-$84.5M4-$75.4M5-$21.8M6-$30.8M7-$40.6M3-$70.8M3
Interest$528.0K4$2.4M5
Income tax$247.0K8-$247.0K4$07$03$03
Net income-$95.8M8-$85.0M4-$76.3M5-$18.2M6-$30.5M7-$39.2M3-$76.3M3
Earnings per share-$1.953-$2.103

Compare Aravive, Inc. with another company

Former names

  • Versartis, Inc.Mar 9, 2011 to Oct 5, 20182

Recent filings

  1. Jan 17, 20248-K
  2. Nov 9, 202310-Q
  3. Nov 3, 20238-K
  4. Oct 3, 20238-K
  5. Sep 19, 20238-K
  6. Sep 5, 2023DEF 14A
  7. Aug 21, 202310-Q
  8. Aug 2, 20238-K
  9. Jun 5, 20238-K
  10. May 25, 20238-K
  11. May 16, 20238-K
  12. May 10, 20238-K
  13. May 10, 202310-Q
  14. Apr 11, 20238-K
  15. Apr 11, 20233

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1